Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages

Molecular Pharmacology

Volumn 79, Issue 4, 2011, Pages 786-792

  Zhu, Chenggang ^a   Solorzano, Carlos ^b   Sahar, Saurabh ^b   Realini, Natalia ^b   Fung, Ernest ^b   Sassone Corsi, Paolo ^b   Piomelli, Daniele ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; ENZYME; HISTONE; LIPOPOLYSACCHARIDE; LUCIFERASE; N ACYLPHOSPHATIDYLETHANOLAMINE SPECIFIC PHOSPHOLIPASE D; PALMIDROL; PHOSPHOLIPASE D; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CATALYSIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME MECHANISM; HISTONE ACETYLATION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPASE D; TRANSCRIPTION, GENETIC;

EID: 79952996326     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.070201     Document Type: Article

References (38)

1. Aung HT, Schroder K, Himes SR, Brion K, van Zuylen W, Trieu A, Suzuki H, Hayashizaki Y, Hume DA, Sweet MJ, et al. (2006) LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J 20:1315-1327. (Pubitemid 44943839)
2. Avalos JL, Bever KM, and Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17:855-868. (Pubitemid 40386946)
3. Calignano A, La Rana G, Giuffrida A, and Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277-281. (Pubitemid 28335039)
4. Capasso R, Izzo AA, Fezza F, Pinto A, Capasso F, Mascolo N, and Di Marzo V (2001) Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 134:945-950. (Pubitemid 33052152)
5. Chatterjee S, Zaman K, Ryu H, Conforto A, and Ratan RR (2001) Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons. Ann Neurol 49:345-354. (Pubitemid 32202788)
6. Costa B, Conti S, Giagnoni G, and Colleoni M (2002) Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br J Pharmacol 137:413-420. (Pubitemid 35221894)
7. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949. (Pubitemid 23026736)
8. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, and Wahli W (1996) The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384:39-43.
9. Endocannabinoid Research Group, De Filippis D, D'Amico A, Cipriano M, Petrosino S, Orlando P, Di Marzo V, and Iuvone T (2010) Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res 61:321-328.
10. Enya K, Hayashi H, Takii T, Ohoka N, Kanata S, Okamoto T, and Onozaki K (2008) The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells. J Leukoc Biol 83:190-199.
11. Flower RJ (2006) Prostaglandins, bioassay and inflammation. Br J Pharmacol 147:S182-S192.
12. Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, and Piomelli D (2007) Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282:1518-1528. (Pubitemid 47076553)
13. Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, and Cuzzocrea S (2008) Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 326:12-23. (Pubitemid 351872139)
14. Glass CK and Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44-55. (Pubitemid 43279752)
15. Kadonaga JT, Courey AJ, Ladika J, and Tjian R (1988) Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242:1566-1570.
16. Kahlich R, Klíma J, Cihla F, Franková V, Masek K, Rosický M, Matousek F, and Bruthans J (1979) Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials. J Hyg Epidemiol Microbiol Immunol 23:11-24. (Pubitemid 9256928)
17. Kemeny L, Koreck A, Kis K, Kenderessy-Szabo A, Bodai L, Cimpean A, Paunescu V, Raica M, and Ghyczy M (2007) Endogenous phospholipid metabolite containing topical product inhibits ultraviolet light-induced inflammation and DNA damage in human skin. Skin Pharmacol Physiol 20:155-161. (Pubitemid 46788287)
18. Leung D, Saghatelian A, Simon GM, and Cravatt BF (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45:4720-4726.
19. Liao M, Zhang Y, and Dufau ML (2008) Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Mol Endocrinol 22:1449-1463. (Pubitemid 351787004)
20. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, and Piomelli D (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67:15-19. (Pubitemid 40069962)
21. LoVerme J, La Rana G, Russo R, Calignano A, and Piomelli D (2005) The search for the palmitoylethanolamide receptor. Life Sci 77:1685-1698. (Pubitemid 41073662)
22. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, and Piomelli D (2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319:1051-1061.
23. Masek K, Perlík F, Klíma J, and Kahlich R (1974) Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections. Eur J Clin Pharmacol 7:415-419.
24. Mazzari S, Canella R, Petrelli L, Marcolongo G, and Leon A (1996) N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 300:227-236.
25. McKinney MK and Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432. (Pubitemid 40995513)
26. Nathan C (2002) Points of control in inflammation. Nature 420:846-852.
27. O'Sullivan SE (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152:576-582.
28. Ohmori Y and Hamilton TA (2001) Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 69:598-604. (Pubitemid 32294845)
29. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. (Pubitemid 29001265)
30. Raetz CR, Garrett TA, Reynolds CM, Shaw WA, Moore JD, Smith DC, Jr., Ribeiro AA, Murphy RC, Ulevitch RJ, Fearns C, Reichart D, Glass CK, Benner C, Subramaniam S, Harkewicz R, Bowers-Gentry RC, Buczynski MW, Cooper JA, Deems RA, and Dennis EA (2006) Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J Lipid Res 47:1097-1111. (Pubitemid 43764706)
31. Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ, and Chapman V (2008) Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10:R43.
32. Schoonjans K, Staels B, and Auwerx J (1996) The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109. (Pubitemid 26247079)
33. Serhan CN, Chiang N, and Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361. (Pubitemid 351595216)
34. Simon GM and Cravatt BF (2006) Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281:26465-26472. (Pubitemid 44401855)
35. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, et al. (2009) Selective N-acylethanolaminehydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci USA 106:20966-20971.
36. Tsuboi K, Takezaki N, and Ueda N (2007) The N-acylethanolamine- hydrolyzing acid amidase (NAAA). Chem Biodivers 4:1914-1925. (Pubitemid 47377209)
37. Won J, Yim J, and Kim TK (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 277:38230-38238. (Pubitemid 35154677)
38. Yoshida M, Kijima M, Akita M, and Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179.